The present invention relates to systems and devices for delivering energy to tissue for a wide variety of applications, including medical procedures (e.g., tissue ablation, resection, cautery, vascular thrombosis, treatment of cardiac arrhythmias and dysrhythmias, electrosurgery, tissue harvest, etc.). In particular, the present invention relates to systems and devices for the delivery of energy with a linear array of antenna components having optimized energy delivery characteristics. In certain embodiments, methods are provided for treating a tissue region (e.g., a tumor) through application of energy with the systems and devices of the present invention.
Ablation is an important therapeutic strategy for treating certain tissues such as benign and malignant tumors, cardiac arrhythmias, cardiac dysrhythmias and tachycardia. Most approved ablation systems utilize radio-frequency (RF) energy as the ablating energy source. Accordingly, a variety of RF based catheters and power supplies are currently available to physicians. However, RF energy has several limitations, including the rapid dissipation of energy in surface tissues resulting in shallow “burns” and failure to access deeper tumor or arrhythmic tissues. Another limitation of RF ablation systems is the tendency of eschar and clot formation to form on the energy emitting electrodes which limits the further deposition of electrical energy.
Microwave energy is an effective energy source for heating biological tissues and is used in such applications as, for example, cancer treatment and preheating of blood prior to infusions. Accordingly, in view of the drawbacks of the traditional ablation techniques, there has recently been a great deal of interest in using microwave energy as an ablation energy source. The advantage of microwave energy over RF is the deeper penetration into tissue, insensitivity to charring, lack of necessity for grounding, more reliable energy deposition, faster tissue heating, and the capability to produce much larger thermal lesions than RF, which greatly simplifies the actual ablation procedures. Accordingly, there are a number of devices under development that utilize electromagnetic energy in the microwave frequency range as the ablation energy source (see, e.g., U.S. Pat. Nos. 4,641,649, 5,246,438, 5,405,346, 5,314,466, 5,800,494, 5,957,969, 6,471,696, 6,878,147, and 6,962,586; each of which is herein incorporated by reference in their entireties).
Unfortunately, current devices configured to deliver microwave energy have drawbacks. For example, current devices produce relatively small lesions because of practical limits in power and treatment time. Current devices have power limitations in that the power carrying capacity of the feedlines are small. Larger diameter feedlines are undesirable, however, because they are less easily inserted percutaneously and may increase procedural complication rates. Microwave devices are also limited to single antennas for most purposes thus limiting the ability to simultaneously treat multiple areas or to place several antennas in close proximity to create large zones of tissue heating. In addition, heating of the feedline at high powers can lead to burns around the area of insertion for the device.
Improved systems and devices for delivering energy to a tissue region are needed. In addition, improved systems and devices capable of delivering microwave energy without corresponding microwave energy loss are needed. In addition, systems and devices capable of percutaneous delivery of microwave energy to a subject's tissue without undesired tissue burning are needed. Furthermore, systems for delivery of desired amounts of microwave energy in a multiple-antenna format without requiring physically large invasive components are needed.
The present invention relates to systems and devices for delivering energy (e.g., microwave energy, radiofrequency energy, ultrasound energy) to tissue for a wide variety of applications, including medical procedures (e.g., tissue ablation, resection, cautery, vascular thrombosis, intraluminal ablation of a hollow viscus, cardiac ablation for treatment of arrhythmias, electrosurgery, tissue harvest, cosmetic surgery, intraocular use, etc.). In particular, the present invention relates to systems and devices for the delivery of microwave energy through a linear array of antenna components with optimized energy delivery characteristics. In certain embodiments, methods are provided for treating a tissue region (e.g., a tumor) through application of microwave energy with the systems and devices of the present invention. The systems and methods of the present invention provide for control of energy delivery (e.g., delivery of different amounts of energy along the length of a catheter) to precisely sculpt an ablation zone.
The present invention provides systems, devices, and methods that employ components for the delivery of energy (e.g., microwave energy, radiofrequency energy, ultrasound energy) at an optimized characteristic impedance through a linear array of antenna components configured to emit energy from varied locations. In some embodiments, an antenna is provided comprising an inner conductor and an outer conductor, wherein the outer conductor is provided in two or more linear segments separated by gaps, such that the length and position of the segments is configured for optimized delivery of energy at the distal end of the antenna. For example, in some embodiments, an antenna comprises a first segment of outer conductor that spans the proximal end of the antenna to a region near the distal end and a second segment of outer conductor distal to the first segment wherein a gap separates or partially separates the first and second segments. The gaps may entirely circumscribe the outer conductor or may only partially circumscribe the outer conductor. In some embodiments, the length of the second segment is λ/2, λ/4, etc., although the present invention is not so limited. In some embodiments one or more additional (e.g., third, fourth, fifth) segments are provided distal to the second segment, each of which is separated from the other by a gap. In some embodiments, the antenna is flexible for purposes of positioning the device around, for example, pulmonary veins and/or tubular structures. In some embodiments, the antenna is terminated with a conductive terminal end that is in electronic communication with the inner conductor. In some embodiments, the conductive terminal end comprises a disc having a diameter substantially identical to the diameter of the outer conductor. Such antenna of the present invention provide multiple peaks of energy delivery along the length of the distal end of the antenna, providing a broader region of energy delivery to target larger regions of tissue. The location and position of the peaks is controlled by selecting the length of the outer conductor segments and by controlling the amount of energy delivered.
In some embodiments, one side of the outer conductor is flat of substantially flat, with the directional pattern radiated from the flat portion to allow the device to seat against the surface of a body.
The present invention is not limited by the nature of the various components of the antenna. A wide variety of components may be used to provide optimal performance, including, but not limited to, the use of a variety of materials for the inner and outer conductors, the use of a variety of materials and configurations for dielectric material between the inner and outer conductors, the use of coolants provided by a variety of different methods.
The present invention is not limited by the type of device or the uses employed. Indeed, the devices may be configured in any desired manner. Likewise, the systems and devices may be used in any application where energy is to be delivered. Such uses include any and all medical, veterinary, and research applications. However, the systems and devices of the present invention may be used in agricultural settings, manufacturing settings, mechanical settings, or any other application where energy is to be delivered.
In some embodiments, the device is configured for percutaneous, intravascular, intracardiac, laparoscopic, or surgical delivery of energy. In some embodiments, the device is configured for delivery of energy to a target tissue or region. The present invention is not limited by the nature of the target tissue or region. Uses include, but are not limited to, treatment of heart arrhythmia, tumor ablation (benign and malignant), control of bleeding during surgery, after trauma, for any other control of bleeding, removal of soft tissue, tissue resection and harvest, treatment of varicose veins, intraluminal tissue ablation of any organ (e.g., to treat esophageal pathologies such as Barrett's Esophagus and esophageal adenocarcinoma, endobronchial treatment of lung tumors, intraluminal treatment of colon or small intestinal pathologies), treatment of bony tumors, normal bone, and benign bony conditions, intraocular uses, uses in cosmetic surgery, treatment of pathologies of the central nervous system including brain tumors and electrical disturbances, sterilization procedures (e.g., ablation of the fallopian tubes) and cauterization of blood vessels or tissue for any purposes. In some embodiments, the surgical application comprises ablation therapy (e.g., to achieve coagulative necrosis). In some embodiments, the surgical application comprises tumor ablation to target, for example, metastatic tumors. In some embodiments, the device is configured for movement and positioning, with minimal damage to the tissue or organism, at any desired location, including but not limited to, the brain, neck, chest, abdomen, and pelvis. In some embodiments, the device is configured for guided delivery, for example, by computerized tomography, ultrasound, magnetic resonance imaging, fluoroscopy, endoscopy, direct vision, and the like.
In certain embodiments, the device comprises a linear antenna, wherein the linear antenna comprises an outer conductor enveloped around an inner conductor, wherein the inner conductor is designed to receive and transmit energy (e.g., microwave energy, radiofrequency energy, ultrasound energy), wherein the outer conductor has therein a series of gap regions (e.g., at least two) positioned along the outer conductor, wherein the inner conductor is exposed at the gap regions, wherein the energy transmitting along the inner conductor is emitted through the gap regions. The device is not limited to a particular number of gap regions (e.g., 2, 3, 4, 5, 6, 10, 20, 50). In some embodiments, the inner conductor comprises a dielectric layer enveloping a central transmission line. In some embodiments, the dielectric element has near-zero conductivity. In some embodiments, the device further comprises a stylet. In some embodiments, the device further comprises a tuning element for adjusting the amount of energy delivered through the gap regions. In certain embodiments, when used in tissue ablation settings, the device is configured to deliver a sufficient amount of energy to ablate a tissue region or cause thrombosis.
In some embodiments, the size of the device is consistent with a 20-gauge needle or a component of similar diameter to a 20-gauge needle. Preferably, the diameter of the device is not larger than a 16-gauge needle (e.g., no larger than an 18-gauge needle). However, in some embodiments, larger devices are used, as desired. For example, in some embodiments, a device consistent with a 12-gauge needle is provided, or the device can be larger in diameter if mounted on an endoscope, for use during laparoscopic or open surgery, or used under direct vision for superficial structures.
In some embodiments, the device further comprises an anchoring element for securing the antenna at a particular tissue region. The device is not limited to a particular type of anchoring element. In some embodiments, the anchoring element is an inflatable balloon (e.g., wherein inflation of the balloon secures the antenna at a particular tissue region). An additional advantage of utilizing an inflatable balloon as an anchoring element is the inhibition of blood flow or air flow to a particular region upon inflation of the balloon. Such air or blood flow inhibition is particularly useful in, for example, cardiac ablation procedures and ablation procedures involving lung tissue, vascular tissue, and gastrointestinal tissue. In some embodiments, the anchoring element is an extension of the antenna designed to engage (e.g., latch onto) a particular tissue region. Further examples include, but are not limited to, the anchoring elements described in U.S. Pat. Nos. 6,364,876, and 5,741,249; each herein incorporated by reference in their entireties.
Thus, in some embodiments, the systems, devices, and methods of the present invention provides an ablation device coupled with a component that provides occlusion of a passageway (e.g., bronchial occlusion). The occlusion component (e.g., inflatable balloon) may be directly mounted on the ablation system or may be used in combination with another component (e.g., an endotracheal or endobronchial tube) associated with the system.
In some embodiments, the devices of the present invention may be mounted onto additional medical procedure devices. For example, the devices may be mounted onto endoscopes, intravascular catheters, or laproscopes. In some embodiments, the devices are mounted onto steerable catheters.
In some embodiments, one or more components of the systems of the present invention may contain a coating (e.g., Teflon or any other insulator) to help reduce heating or to impart other desired properties to the component or system.
In some embodiments, the device further comprises a tuning element for adjusting the amount of energy delivered to the tissue region. In some embodiments, the tuning element is manually adjusted by a user of the system. In some embodiments, the device is pretuned to the desired tissue and is fixed throughout the procedure. In some embodiments, the tuning element is automatically adjusted and controlled by a processor of the present invention. In some embodiments, the processor adjusts the energy delivery over time to provide constant energy throughout a procedure, taking into account any number of desired factors including, but not limited to, heat, nature and/or location of target tissue, size of lesion desired, length of treatment time, proximity to sensitive organ areas, and the like. In some embodiments, the system comprises a sensor that provides feedback to the user or to a processor that monitors the function of the device continuously or at time points. The sensor may record and/or report back any number of properties, including, but not limited to, heat at one or more positions of a components of the system, heat at the tissue, property of the tissue, and the like. The sensor may be in the form of an imaging device such as CT, ultrasound, magnetic resonance imaging, or any other imaging device. In some embodiments, particularly for research application, the system records and stores the information for use in future optimization of the system generally and/or for optimization of energy delivery under particular conditions (e.g., patient type, tissue type, size and shape of target region, location of target region, etc.).
In certain embodiments, the present invention provides a system for ablation therapy, comprising a power distributor.
In certain embodiments, the present invention provides a system for ablation therapy, comprising a power distributor, a power splitter, and a device described herein (e.g., having a linear array of antenna components configured to emit energy from varied locations). In some embodiments, the power splitter is configured to provide the same power throughout the device. In some embodiments, the power splitter is configured to provide a different amount of power to different regions of the antenna, as so desired by the user or directed by a tuning element. In some embodiments, the system comprises more than one ablation device as described herein (e.g., having a linear array of antenna components configured to emit energy from varied locations) for purposes of, for example, phasing the energy delivery from the devices in a constructive or destructive manner. The devices of the present invention may be combined or utilized with any kind of additional ablation devices (see, e.g., U.S. Pat. Nos. 7,033,352, 6,893,436, 6,878,147, 6,823,218, 6,817,999, 6,635,055, 6,471,696, 6,383,182, 6,312,427, 6,287,302, 6,277,113, 6,251,128, 6,245,062, 6,026,331, 6,016,811, 5,810,803, 5,800,494, 5,788,692, 5,405,346, 4,494,539, U.S. patent application Ser. Nos. 11/237,136, 11/236,985, 10/980,699, 10/961,994, 10/961,761, 10/834,802, 10/370,179, 09/847,181; U.S. Provisional Patent Nos. 60/785,690, 60/785,467, and 60/785,466; Great Britain Patent Application Nos. 2,406,521, 2,388,039; European Patent No. 1395190; and International Patent Application Nos. WO 06/008481, WO 06/002943, WO 05/034783, WO 04/112628, WO 04/033039, WO 04/026122, WO 03/088858, WO 03/039385 WO 95/04385; each herein incorporated by reference in their entireties).
In certain embodiments, the present invention provides a method of treating a tissue region, comprising providing a tissue region and a device described herein (e.g., having a linear array of antenna components configured to emit energy from varied locations); positioning a portion of the device in the vicinity of the tissue region, and delivering an amount of energy with the device to the tissue region. In some embodiments, the tissue region is a tumor. In some embodiments, the delivering of the energy results in, for example, the ablation of the tissue region and/or thrombosis of a blood vessel, and/or electroporation of a tissue region. In some embodiments, the user is able to control the release of energy through different regions of the device and control the amount of energy delivered through each region of the device for purposes of precisely sculpting an ablation zone. In some embodiments, the tissue region is a tumor. In some embodiments, the tissue region comprises one or more of the heart, liver, genitalia, stomach, lung, skin, breast, large intestine, small intestine, brain, neck, bone, kidney, muscle, tendon, blood vessel, prostate, bladder, and spinal cord.
In some embodiments, energy is delivered to the tissue region in different intensities and from different locations within the device. For example, certain regions of the tissue region may be treated through one portion of the device, while other regions of the tissue may be treated through a different portion of the device. In addition, two or more regions of the device may simultaneously deliver energy to a particular tissue region so as to achieve constructive phase interference (e.g., wherein the emitted energy achieves a synergistic effect). In other embodiments, two or more regions of the device may deliver energy so as to achieve a destructive interference effect. In some embodiments, the method further provides additional devices for purposes of achieving constructive phase interference and/or destructive phase interference. In some embodiments, phase interference (e.g., constructive phase interference, destructive phase interference), between one or more devices, is controlled by a processor, a tuning element, a user, and/or a power splitter.
In some embodiments, the device is configured for percutaneous, intravascular, intracardiac, laparoscopic, endoscopic, or surgical delivery of energy. In some embodiments, the device is configured for delivery of energy to a target tissue or region. The present invention is not limited by the nature of the target tissue or region. The device may be rigid or flexible, and mounted on a number of different delivery tools including but not limited to: a percutaneous needle shaft, a laparoscope, an endoscope, intravascular catheters, etc.
The systems, devices, and methods of the present invention may be used in conjunction with other systems, device, and methods (see, e.g., U.S. Provisional Patent Nos. 60/785,466, 60/785,467, and 60/785,690, each of which is herein incorporated by reference in their entireties). For example, the systems, devices, and methods of the present invention may be used with other ablation devices, other medical devices, diagnostic methods and reagents, imaging methods and reagents, and therapeutic methods and agents. In some embodiments, the devices of the present invention may be mounted onto additional medical procedure devices. For example, the devices may be mounted onto endoscopes, intravascular catheters, or laproscopes. In some embodiments, the devices are mounted onto steerable catheters. Use may be concurrent or may occur before or after another intervention. The present invention contemplates the use systems, devices, and methods of the present invention in conjunction with any other medical interventions.
In some embodiments, the energy delivery systems of the present invention utilize coolant systems so as to reduce undesired heating within and along an energy delivery device (e.g., tissue ablation catheter). The systems of the present invention are not limited to a particular cooling system mechanism. In some embodiments, the systems are designed to circulate a coolant (e.g., air, liquid, etc.) throughout an energy delivery device such that the coaxial transmission line(s) and antenna(e) temperatures are reduced. In some embodiments, the systems utilize energy delivery devices having therein channels designed to accommodate coolant circulation. In some embodiments, the systems provide a coolant sheath wrapped around the antenna or portions of the antenna for purposes of cooling the antenna externally (see, e.g., U.S. patent application Ser. No. 11/053,987; herein incorporated by reference in its entirety). In some embodiments, the systems utilize energy delivery devices having a conductive covering around the antenna for purposes of limiting dissipation of heat onto surrounding tissue (see, e.g., U.S. Pat. No. 5,358,515; herein incorporated by reference in its entirety).
The present invention relates to systems and devices for delivering energy to tissue for a wide variety of applications, including medical procedures (e.g., tissue ablation, resection, cautery, vascular thrombosis, treatment of cardiac arrhythmias and dysrhythmias, electrosurgery, tissue harvest, etc.). In particular, the present invention relates to systems and devices for the delivery of energy with a linear array of antenna components configured to emit energy from varied locations having optimized energy delivery characteristics. In certain embodiments, methods are provided for treating a tissue region (e.g., a tumor) through application of energy with the systems and devices of the present invention.
In preferred embodiments, the systems, devices, and methods of the present invention employ microwave energy. The use of microwave energy in the ablation of tissue has numerous advantages. For example, microwaves have a broad field of power density (e.g., approximately 2 cm surrounding an antenna depending on the wavelength of the applied energy) with a correspondingly large zone of active heating, thereby allowing uniform tissue ablation both within a targeted zone and in perivascular regions (see, e.g., International Publication No. WO 2006/004585; herein incorporated by reference in its entirety). In addition, microwave energy has the ability to ablate large or multiple zones of tissue using multiple probes with more rapid tissue heating. Microwave energy has an ability to penetrate tissue to create deep lesions with less surface heating. Energy delivery times are shorter than with radiofrequency energy and probes can heat tissue sufficiently to create an even and symmetrical lesion of predictable and controllable depth. Microwave energy is generally safe when used near vessels. Also, microwaves do not rely on electrical conduction as it radiates through tissue, fluid/blood, as well as air. Therefore, microwave energy can be used in tissue, bone, lumens, lungs, and intravascularly.
The illustrated embodiments provided below describe the systems and devices of the present invention in terms of medical applications (e.g., ablation of tissue through delivery of microwave energy). However, it should be appreciated that the systems and devices of the present invention are not limited to medical applications. In addition, the illustrated embodiments describe the systems and devices of the present invention in terms of medical devices configured for tissue ablation. It should be appreciated that the systems and devices of the present invention are not limited to medical devices configured for tissue ablation. The illustrated embodiments describe the systems and devices of the present invention in terms of microwave energy. It should be appreciated that the systems and devices of the present invention are not limited to a particular type of energy (e.g., radiofrequency energy).
The systems and devices of the present invention provide numerous advantages over the currently available systems and devices. For example, a major drawback with currently available medical devices that utilize microwave energy is that the emitted energy is provided locally, thereby precluding delivery of energy over a deeper and denser scale. The devices of the present invention overcome this limitation by providing an applicator device having a linear array of antenna components configured to deliver energy (e.g., microwave energy) over a wider and deeper scale (e.g., as opposed to local delivery). Such a device is particularly useful in the tissue ablation of dense and/or thick tissue regions (e.g., tumors, organ lumens) and particularly deep tissue regions (e.g., large cardiac areas, brains, bones).
Certain preferred embodiments of the present invention are described below. The present invention is not limited to these embodiments.
Still referring to
Still referring to
In some embodiments, the power distribution system 120 is configured with a variable power splitter so as to provide varying energy levels to different regions of a device (e.g., a linear array of antenna components configured to emit energy from varied locations). In some embodiments, the power splitter is used to feed multiple energy delivery devices with separate energy signals. In some embodiments, the power splitter electrically isolates the energy delivered to each energy delivery device so that, for example, if one of the devices experiences an increased load as a result of increased temperature deflection, the energy delivered to that unit is altered (e.g., reduced, stopped) while the energy delivered to alternate devices is unchanged. The present invention is not limited to a particular type of power splitter. In some embodiments, the power splitter is configured to receive energy from a power generator and provide energy to additional system components (e.g., energy delivery devices). In some embodiments the power splitter is able to connect with one or more additional system components (e.g., 1, 2, 3, 4, 5, 7, 10, 15, 20, 25, 50, 100, 500 . . . ). In some embodiments, the power splitter is configured to deliver variable amounts of energy to different regions within an energy delivery device for purposes of delivering variable amounts of energy from different regions of the device. In some embodiments, the power splitter is used to provide variable amounts of energy to multiple energy delivery devices for purposes of treating a tissue region. In preferred embodiments, the power splitter is configured to operate within a system comprising a processor, an energy delivery device, a temperature adjustment system, a power splitter, a tuning system, and/or an imaging system.
In some embodiments, where multiple antennas are employed, the system of the present invention may be configured to run them simultaneously or sequentially (e.g., with switching). In some embodiments, the system is configured to phase the fields for constructive or destructive interference. Phasing may also be applied to different elements within a single antenna.
Still referring to
Still referring to
Still referring to
Still referring to
Still referring to
Still referring to
Still referring to
Still referring to
As demonstrated in
Still referring to
Still referring to
In some embodiments, the device further comprises an anchoring element for securing the antenna at a particular tissue region. The device is not limited to a particular type of anchoring element. In some embodiments, the anchoring element is an inflatable balloon (e.g., wherein inflation of the balloon secures the antenna at a particular tissue region). An additional advantage of utilizing an inflatable balloon as an anchoring element is the inhibition of blood flow or air flow to a particular region upon inflation of the balloon. Such air or blood flow inhibition is particularly useful in, for example, cardiac ablation procedures and ablation procedures involving lung tissue, vascular tissue, and gastrointestinal tissue. In some embodiments, the anchoring element is an extension of the antenna designed to engage (e.g., latch onto) a particular tissue region. Further examples include, but are not limited to, the anchoring elements described in U.S. Pat. Nos. 6,364,876, and 5,741,249; each herein incorporated by reference in their entireties.
In some embodiments, the device is configured to attach with a detachable handle. The present invention is not limited to a particular type of detachable handle. In preferred embodiments, the detachable handle is configured to connect with multiple devices (e.g., 1, 2, 3, 4, 5, 10, 20, 50 . . . ) for purposes of controlling the energy delivery through such devices.
In some embodiments, the device is designed to physically surround a particular tissue region for purposes of energy delivery (e.g., the device may be flexibly shaped around a particular tissue region). For example, in some embodiments, the device may be flexibly shaped around a blood vessel (e.g., pulmonary vein) for purposes of delivering energy to a precise region within the tissue.
In use, the applicator device is particularly useful for tissue ablation of dense and/or thick tissue regions (e.g., tumors, organ lumens) and particularly deep tissue regions (e.g., large cardiac areas, brains, bones). Indeed, the applicator device may be positioned inside or in the vicinity of a tissue requiring a tissue ablation (e.g., a tumor). Whereas standard ablation instruments only permit localized delivery of microwave energy to a tissue to be treated, the devices of the present invention can simultaneously deliver energy to a plurality of locations or a broader area within the tissue. In some embodiments, the devices of the present invention are used in the ablation of a tissue region having high amounts of air and/or blood flow (e.g., lung tissue, cardiac tissue, gastrointestinal tissue, vascular tissue). In some embodiments involving ablation of tissue regions having high amounts of air and/or blood flow, an element is further utilized for inhibiting the air and/or blood flow to that tissue region. The present invention is not limited to a particular air and/or blood flow inhibition element. In some embodiments, the device is combined with an endotracheal/endobronchial tube. In some embodiments, a balloon attached with the device may be inflated at the tissue region for purposes of securing the device(s) within the desired tissue region, and inhibiting blood and/or air flow to the desired tissue region.
In addition, the devices of the present invention are configured to deliver energy from different regions of the device (e.g., outer conductor segment gaps) at different times (e.g., controlled by a user) and at different energy intensities (e.g., controlled by a user). Such control over the device permits the phasing of energy delivery fields for purposes of achieving constructive phase interference at a particular tissue region or destructive phase interference at a particular tissue region. For example, a user may employ energy delivery through two (or more) closely positioned outer conductor segments so as to achieve a combined energy intensity (e.g., constructive phase interference). Such a combined energy intensity may be useful in particularly deep or dense tissue regions. In addition, such a combined energy intensity may be achieved through utilization of two (or more) devices. In some embodiments, phase interference (e.g., constructive phase interference, destructive phase interference), between one or more devices, is controlled by a processor, a tuning element, a user, and/or a power splitter.
The systems and devices of the present invention may be combined within various system/kit embodiments. For example, the present invention provides kits comprising one or more of a generator, a power distribution system, an applicator, along with any one or more accessory agents (e.g., surgical instruments, software for assisting in procedure, processors, temperature monitoring devices, etc.). The present invention is not limited to any particular accessory agent. Additionally, the present invention contemplates kits comprising instructions (e.g., ablation instructions, pharmaceutical instructions) along with the systems and devices of the present invention and/or a pharmaceutical agent (e.g., a sedating medication, a topical antiseptic, a topical anesthesia).
The devices of the present invention may be used in any medical procedure (e.g., percutaneous or surgical) involving delivery of energy (e.g., microwave energy) to a tissue region. The present invention is not limited to a particular type or kind of tissue region (e.g., brain, liver, heart, breast, skin, blood vessels, foot, lung, bone, etc.). For example, the systems of the present invention find use in ablating tumor regions. In such uses, the applicator device is inserted into, for example, a subject such that the linear array of antenna components are positioned in the vicinity of and/or within a desired tissue region (e.g., a dense tumor). Next, the generator is used to provide a desired amount of microwave energy to the power distribution system at a characteristic impedance level, which in turn provides the energy at a characteristic impedance level to the applicator. Next, a desired amount of microwave energy is delivered to the desired tissue region (e.g., tumor) through the outer conductor segment gaps within the outer conductor (see, e.g.,
In some embodiments, the software is configured for imaging equipment (e.g., CT, MRI, ultrasound). In some embodiments, the imaging equipment software allows a user to make predictions based upon known thermodynamic and electrical properties of tissue and location of the antenna(s). In some embodiments, the imaging software allows the generation of a three-dimensional map of the location of a tissue region (e.g., tumor, arrhythmia), location of the antenna(s), and to generate a predicted map of the ablation zone.
In some embodiments, the devices of the present invention may be mounted onto additional medical procedure devices. For example, the devices may be mounted onto endoscopes, intravascular catheters, or laproscopes. In some embodiments, the devices are mounted onto steerable catheters. Any desirable configuration may be used. In some embodiments, a flexible catheter is mounted on an endoscope, intravascular catheter or laparoscope. For example, the flexible catheter, in some embodiments, has multiple joints (e.g., like a centipede) that permits bending and steering as desired to navigate to the desired location for treatment.
All publications and patents mentioned in the above specification are herein incorporated by reference. Various modifications and variations of the described method and system of the invention will be apparent to those skilled in the art without departing from the scope and spirit of the invention. Although the invention has been described in connection with specific preferred embodiments, it should be understood that the invention as claimed should not be unduly limited to such specific embodiments. Indeed, various modifications of the described modes for carrying out the invention that are obvious to those skilled in the relevant fields are intended to be within the scope of the following claims.
The present application claims priority to U.S. Provisional Application Ser. No. 60/831,055, filed Jul. 14, 2006, herein incorporated by reference in its entirety.
Number | Name | Date | Kind |
---|---|---|---|
3800552 | Sollami | Apr 1974 | A |
3838242 | Goucher | Sep 1974 | A |
3991770 | LeVeen | Nov 1976 | A |
4057064 | Morrison | Nov 1977 | A |
4074718 | Morrison | Feb 1978 | A |
4312364 | Convert | Jan 1982 | A |
4375220 | Matvias | Mar 1983 | A |
4446874 | Vaguine | May 1984 | A |
4494539 | Zenitani | Jan 1985 | A |
4534347 | Taylor | Aug 1985 | A |
4557272 | Carr | Dec 1985 | A |
4586491 | Carpenter | May 1986 | A |
4589424 | Vaguine | May 1986 | A |
4601296 | Yerushalmi et al. | Jul 1986 | A |
4621642 | Chen | Nov 1986 | A |
4627435 | Hoskin | Dec 1986 | A |
4641649 | Walinsky | Feb 1987 | A |
4643186 | Rosen | Feb 1987 | A |
4662383 | Sogawa | May 1987 | A |
4700716 | Kasevich et al. | Oct 1987 | A |
4712559 | Turner | Dec 1987 | A |
4776086 | Kasevich | Oct 1988 | A |
4790311 | Ruiz | Dec 1988 | A |
4800899 | Elliott et al. | Jan 1989 | A |
4860752 | Turner | Aug 1989 | A |
4880015 | Nierman | Nov 1989 | A |
4901719 | Trenconsky | Feb 1990 | A |
4945912 | Langberg | Aug 1990 | A |
4974587 | Turner | Dec 1990 | A |
5007437 | Sterzer | Apr 1991 | A |
5026959 | Ito | Jun 1991 | A |
5057104 | Chess | Oct 1991 | A |
5057106 | Kasevich | Oct 1991 | A |
5074861 | Schneider | Dec 1991 | A |
RE33791 | Carr | Jan 1992 | E |
5097845 | Fetter | Mar 1992 | A |
5098429 | Sterzer | Mar 1992 | A |
5129396 | Rosen | Jul 1992 | A |
5150717 | Rosen et al. | Sep 1992 | A |
5167619 | Wuchinich | Dec 1992 | A |
5211625 | Sakurai | May 1993 | A |
5213561 | Weinstein | May 1993 | A |
5246438 | Langberg | Sep 1993 | A |
5248312 | Langberg | Sep 1993 | A |
5275597 | Higgins | Jan 1994 | A |
5277201 | Stern | Jan 1994 | A |
5281213 | Midler | Jan 1994 | A |
5281217 | Edwards | Jan 1994 | A |
5295955 | Rosen | Mar 1994 | A |
5300099 | Rudie | Apr 1994 | A |
5301687 | Wong | Apr 1994 | A |
5314466 | Stern | May 1994 | A |
5344418 | Ghaffari | Sep 1994 | A |
5344435 | Turner | Sep 1994 | A |
5348554 | Imran | Sep 1994 | A |
5358515 | Hurter | Oct 1994 | A |
5364392 | Warner et al. | Nov 1994 | A |
5366490 | Edwards | Nov 1994 | A |
5369251 | King | Nov 1994 | A |
5370678 | Edwards | Dec 1994 | A |
5405346 | Grundy | Apr 1995 | A |
5431649 | Muller | Jul 1995 | A |
5433740 | Yamaguchi | Jul 1995 | A |
5456684 | Schmidt | Oct 1995 | A |
5462556 | Powers | Oct 1995 | A |
5472423 | Gronauer | Dec 1995 | A |
5480417 | Hascoet | Jan 1996 | A |
5489256 | Adair | Feb 1996 | A |
5507743 | Edwards | Apr 1996 | A |
5531677 | Lundquist | Jul 1996 | A |
5540649 | Bonnell | Jul 1996 | A |
5559295 | Sheryll | Sep 1996 | A |
5575794 | Walus | Nov 1996 | A |
5578029 | Trelles | Nov 1996 | A |
5591227 | Dinh | Jan 1997 | A |
5597146 | Putman | Jan 1997 | A |
5599295 | Rosen | Feb 1997 | A |
5599352 | Dinh | Feb 1997 | A |
5603697 | Diederich | Feb 1997 | A |
5620479 | Diederich | Apr 1997 | A |
5643175 | Adair | Jul 1997 | A |
5647871 | Levine | Jul 1997 | A |
5688267 | Panescu et al. | Nov 1997 | A |
5693082 | Warner | Dec 1997 | A |
5697949 | Giurtino | Dec 1997 | A |
5716389 | Walinsky | Feb 1998 | A |
5737384 | Fenn | Apr 1998 | A |
5741249 | Moss | Apr 1998 | A |
5755752 | Segal | May 1998 | A |
5755754 | Rudie | May 1998 | A |
5759200 | Azar | Jun 1998 | A |
5776129 | Mersch | Jul 1998 | A |
5776176 | Rudie | Jul 1998 | A |
5782827 | Gough | Jul 1998 | A |
5788692 | Campbell | Aug 1998 | A |
5788694 | Vancaillie | Aug 1998 | A |
5800494 | Campbell | Sep 1998 | A |
5810803 | Moss | Sep 1998 | A |
5810804 | Gough | Sep 1998 | A |
5849029 | Eckhouse | Dec 1998 | A |
5902251 | Vanhooydonk | May 1999 | A |
5904709 | Arndt | May 1999 | A |
5921935 | Hickey | Jul 1999 | A |
5957969 | Warner | Sep 1999 | A |
5963082 | Dick | Oct 1999 | A |
5995875 | Biewett | Nov 1999 | A |
6002968 | Edwards | Dec 1999 | A |
6012457 | Lesh | Jan 2000 | A |
6016811 | Knopp | Jan 2000 | A |
6026331 | Feldberg | Feb 2000 | A |
6044846 | Edwards | Apr 2000 | A |
6051018 | Larsen | Apr 2000 | A |
6056744 | Edwards | May 2000 | A |
6067475 | Graves | May 2000 | A |
6073052 | Zelickson | Jun 2000 | A |
6083255 | Laufer | Jul 2000 | A |
6086529 | Arndt | Jul 2000 | A |
6091995 | Ingle et al. | Jul 2000 | A |
6097985 | Zasevich | Aug 2000 | A |
6102885 | Bass | Aug 2000 | A |
6104959 | Spertell | Aug 2000 | A |
6106524 | Eggers | Aug 2000 | A |
6120496 | Whayne et al. | Sep 2000 | A |
6165163 | Chien | Dec 2000 | A |
6174307 | Daniel | Jan 2001 | B1 |
6182666 | Dobak, III | Feb 2001 | B1 |
6188930 | Carson | Feb 2001 | B1 |
6190382 | Ormsby | Feb 2001 | B1 |
6208903 | Richards | Mar 2001 | B1 |
6210323 | Gilhuly | Apr 2001 | B1 |
6223085 | Dann | Apr 2001 | B1 |
6312427 | Berube | Apr 2001 | B1 |
6230060 | Mawhinney | May 2001 | B1 |
6235022 | Hallock et al. | May 2001 | B1 |
6241725 | Cosman | Jun 2001 | B1 |
6245062 | Berube | Jun 2001 | B1 |
6246784 | Summers | Jun 2001 | B1 |
6246905 | Mogul | Jun 2001 | B1 |
6251128 | Knopp | Jun 2001 | B1 |
6254598 | Edwards | Jul 2001 | B1 |
6273884 | Altshuler | Aug 2001 | B1 |
6273885 | Koop | Aug 2001 | B1 |
6273886 | Edwards et al. | Aug 2001 | B1 |
6277113 | Berube | Aug 2001 | B1 |
6287302 | Berube | Sep 2001 | B1 |
6306130 | Anderson | Oct 2001 | B1 |
6306132 | Moorman | Oct 2001 | B1 |
6325796 | Berube | Dec 2001 | B1 |
6347251 | Deng | Feb 2002 | B1 |
6355033 | Moorman | Mar 2002 | B1 |
6364876 | Erb | Apr 2002 | B1 |
6383182 | Berube | May 2002 | B1 |
6395803 | Angeletakis | May 2002 | B1 |
6398781 | Goble | Jun 2002 | B1 |
6402742 | Blewett | Jun 2002 | B1 |
6427089 | Knowlton | Jul 2002 | B1 |
6435872 | Nagel | Aug 2002 | B1 |
6461351 | Woodruff | Oct 2002 | B1 |
6461352 | Morgan | Oct 2002 | B2 |
6471696 | Berube | Oct 2002 | B1 |
6500174 | Maguire | Dec 2002 | B1 |
6506189 | Rittman | Jan 2003 | B1 |
6514249 | Maguire | Feb 2003 | B1 |
6524308 | Muller | Feb 2003 | B1 |
6527768 | Berube | Mar 2003 | B2 |
6530922 | Cosman | Mar 2003 | B2 |
6546077 | Chornenky | Apr 2003 | B2 |
6575969 | Rittman, III | Jun 2003 | B1 |
6577903 | Cronin | Jun 2003 | B1 |
6582426 | Moorman | Jun 2003 | B2 |
6582486 | Delpiano | Jun 2003 | B1 |
6585733 | Wellman | Jul 2003 | B2 |
6593395 | Angeletakis | Jul 2003 | B2 |
6602074 | Suh | Aug 2003 | B1 |
6622731 | Daniel | Sep 2003 | B2 |
6635055 | Cronin | Oct 2003 | B1 |
6638277 | Schaefer et al. | Oct 2003 | B2 |
6652520 | Moorman | Nov 2003 | B2 |
6663625 | Ormsby | Dec 2003 | B1 |
6666579 | Jensen | Dec 2003 | B2 |
6683625 | Muthusamy | Jan 2004 | B2 |
6694163 | Vining | Feb 2004 | B1 |
6699240 | Francischelli | Mar 2004 | B2 |
6702576 | Fischer | Mar 2004 | B2 |
6709271 | Yin | Mar 2004 | B2 |
6740107 | Loeb | May 2004 | B2 |
6749606 | Keast | Jun 2004 | B2 |
6752767 | Turovskiy | Jun 2004 | B2 |
D493531 | Padain | Jul 2004 | S |
6770070 | Balbierz | Aug 2004 | B1 |
6780178 | Palanker | Aug 2004 | B2 |
6673068 | Berube | Oct 2004 | B1 |
6802840 | Chin | Oct 2004 | B2 |
6817976 | Rovegno | Nov 2004 | B2 |
6817999 | Berube | Nov 2004 | B2 |
6823218 | Berube | Nov 2004 | B2 |
6837712 | Qian | Jan 2005 | B2 |
6847848 | Sterzer | Jan 2005 | B2 |
6849075 | Bertolero et al. | Feb 2005 | B2 |
6852091 | Edwards | Feb 2005 | B2 |
6866624 | Chornenky | Mar 2005 | B2 |
6866663 | Edwards | Mar 2005 | B2 |
6869431 | Maguire | Mar 2005 | B2 |
6878147 | Prakash | Apr 2005 | B2 |
6890968 | Angeletakis | May 2005 | B2 |
6893436 | Woodard | May 2005 | B2 |
6898454 | Atalar | May 2005 | B2 |
D507649 | Padain | Jul 2005 | S |
6918905 | Neuberger | Jul 2005 | B2 |
6924325 | Qian | Aug 2005 | B2 |
6957108 | Turner | Oct 2005 | B2 |
6962586 | Berube | Nov 2005 | B2 |
6972016 | Hill | Dec 2005 | B2 |
6976986 | Berube | Dec 2005 | B2 |
6994546 | Fischer | Feb 2006 | B2 |
7022105 | Edwards | Apr 2006 | B1 |
7033352 | Gauthier | Apr 2006 | B1 |
7097641 | Arless | Aug 2006 | B1 |
7101369 | van der Welde | Sep 2006 | B2 |
7115126 | Berube | Oct 2006 | B2 |
7128739 | Prakash | Oct 2006 | B2 |
7142633 | Eberhard | Nov 2006 | B2 |
7147632 | Prakash | Dec 2006 | B2 |
7153298 | Cohen | Dec 2006 | B1 |
7156842 | Sartor et al. | Jan 2007 | B2 |
7160289 | Cohen | Jan 2007 | B2 |
7160292 | Moorman | Jan 2007 | B2 |
7182762 | Bortkiewicz | Feb 2007 | B2 |
7184824 | Hashimshony | Feb 2007 | B2 |
7197363 | Prakash | Mar 2007 | B2 |
7233820 | Gilboa | Jun 2007 | B2 |
7244254 | Brace | Jul 2007 | B2 |
7263997 | Madsen | Sep 2007 | B2 |
7266407 | Li | Sep 2007 | B2 |
7282049 | Orszulak | Oct 2007 | B2 |
7311703 | Turovskiy | Dec 2007 | B2 |
7318824 | Prakash | Jan 2008 | B2 |
7324104 | Bitter | Jan 2008 | B1 |
7331960 | Schaer | Feb 2008 | B2 |
7381208 | van der Walt | Jun 2008 | B2 |
7400929 | Zelickson et al. | Jul 2008 | B2 |
7402140 | Spero | Jul 2008 | B2 |
7410484 | Littrup | Aug 2008 | B2 |
7467015 | Van der Weide et al. | Dec 2008 | B2 |
7473219 | Glenn | Jan 2009 | B1 |
7527623 | Prakash | May 2009 | B2 |
7594313 | Prakash | Sep 2009 | B2 |
7601149 | DiCarlo et al. | Oct 2009 | B2 |
7625369 | Abboud | Dec 2009 | B2 |
7722620 | Truckai | May 2010 | B2 |
7731677 | Sakurai | Jun 2010 | B2 |
7815637 | Ormsby | Oct 2010 | B2 |
7826904 | Appling | Nov 2010 | B2 |
7862559 | Prakash | Jan 2011 | B2 |
7875024 | Turovskiy | Jan 2011 | B2 |
8035570 | Prakash | Oct 2011 | B2 |
8059059 | Bonn | Nov 2011 | B2 |
8093500 | Deborski | Jan 2012 | B2 |
8109895 | Williams | Feb 2012 | B2 |
8147511 | Perry | Apr 2012 | B2 |
8152799 | Ormsby | Apr 2012 | B2 |
8155418 | Delso | Apr 2012 | B2 |
8235981 | Prakash | Aug 2012 | B2 |
8357148 | Boulais | Jan 2013 | B2 |
8403924 | Behnke | Mar 2013 | B2 |
8430871 | Brannan | Apr 2013 | B2 |
8454589 | Deno | Jun 2013 | B2 |
8515554 | Carr | Aug 2013 | B2 |
8523854 | Willyard | Sep 2013 | B2 |
8540710 | Johnson | Sep 2013 | B2 |
8574227 | Hancock | Nov 2013 | B2 |
8643561 | Prakash | Feb 2014 | B2 |
8653828 | Hancock | Feb 2014 | B2 |
8655454 | Prakash | Feb 2014 | B2 |
8672932 | van der Weide | Mar 2014 | B2 |
8747398 | Behnke | Jun 2014 | B2 |
8764744 | Brannan | Jul 2014 | B2 |
8932281 | Brannan | Jan 2015 | B2 |
8934989 | Ormsby | Jan 2015 | B2 |
8945111 | Brannan et al. | Feb 2015 | B2 |
8968290 | Brannan | Mar 2015 | B2 |
9008793 | Cosman | Apr 2015 | B1 |
9011421 | Brannan | Apr 2015 | B2 |
9017319 | Brannan | Apr 2015 | B2 |
9041616 | Prakash | May 2015 | B2 |
9072532 | van der Weide | Jul 2015 | B2 |
9113926 | Brannan | Aug 2015 | B2 |
9119649 | van der Weide | Sep 2015 | B2 |
9119650 | Brannan | Sep 2015 | B2 |
9161811 | Cronin | Oct 2015 | B2 |
9173706 | Rossetto | Nov 2015 | B2 |
9192436 | Willyard | Nov 2015 | B2 |
9192438 | Thiel | Nov 2015 | B2 |
9198725 | Willyard | Dec 2015 | B2 |
9220441 | Yoo | Dec 2015 | B2 |
20010020166 | Daly et al. | Sep 2001 | A1 |
20010039416 | Moorman | Nov 2001 | A1 |
20010049524 | Morgan | Dec 2001 | A1 |
20020022836 | Goble | Feb 2002 | A1 |
20020026187 | Swanson et al. | Feb 2002 | A1 |
20020026188 | Balbierz et al. | Feb 2002 | A1 |
20020040185 | Atalar et al. | Apr 2002 | A1 |
20020072742 | Schaefer | Jun 2002 | A1 |
20020087151 | Mody | Jul 2002 | A1 |
20020087157 | Sliwa et al. | Jul 2002 | A1 |
20020173780 | Altshuler | Nov 2002 | A1 |
20020183740 | Edwards | Dec 2002 | A1 |
20030032951 | Rittman et al. | Feb 2003 | A1 |
20030060813 | Loeb | Mar 2003 | A1 |
20030065317 | Rudie et al. | Apr 2003 | A1 |
20030088242 | Prakash | May 2003 | A1 |
20030120268 | Bertolero | Jun 2003 | A1 |
20030130711 | Pearson et al. | Jul 2003 | A1 |
20040030367 | Yamaki et al. | Feb 2004 | A1 |
20040068208 | Cimino et al. | Apr 2004 | A1 |
20040082859 | Schaer | Apr 2004 | A1 |
20040116921 | Sherman | Jun 2004 | A1 |
20040133254 | Sterzer | Jul 2004 | A1 |
20040158237 | Abboud | Aug 2004 | A1 |
20040186517 | Hill | Sep 2004 | A1 |
20040199154 | Nahon | Oct 2004 | A1 |
20040215131 | Sakurai et al. | Oct 2004 | A1 |
20040215294 | Littrup | Oct 2004 | A1 |
20040243004 | Carr | Dec 2004 | A1 |
20040243200 | Turner | Dec 2004 | A1 |
20040249272 | Carr | Dec 2004 | A1 |
20040267248 | Duong | Dec 2004 | A1 |
20050011885 | Seghatol | Jan 2005 | A1 |
20050015081 | Turovskiy | Jan 2005 | A1 |
20050075629 | Chapelon | Apr 2005 | A1 |
20050107870 | Wang | May 2005 | A1 |
20050109900 | Schilt | May 2005 | A1 |
20050113824 | Sartor | May 2005 | A1 |
20050143726 | Bortkiewicz | Jun 2005 | A1 |
20050149010 | Turovskiy | Jul 2005 | A1 |
20050165389 | Swain | Jul 2005 | A1 |
20050177209 | Leung et al. | Aug 2005 | A1 |
20050245919 | van der Welde | Nov 2005 | A1 |
20050245920 | Vitullo et al. | Nov 2005 | A1 |
20060064083 | Khalaj | Mar 2006 | A1 |
20060079886 | Orszulak et al. | Apr 2006 | A1 |
20060094956 | Vismanathan | May 2006 | A1 |
20060106281 | Boulais | May 2006 | A1 |
20060122625 | Truckai | Jun 2006 | A1 |
20060129140 | Todd et al. | Jun 2006 | A1 |
20060155270 | Hancock | Jul 2006 | A1 |
20060171506 | Lovoi et al. | Aug 2006 | A1 |
20060189973 | van der Weide | Aug 2006 | A1 |
20060200026 | Wallace et al. | Sep 2006 | A1 |
20060200120 | DiCarlo | Sep 2006 | A1 |
20060224220 | Zelickson | Oct 2006 | A1 |
20060264921 | Deutsch et al. | Nov 2006 | A1 |
20060276780 | Brace et al. | Dec 2006 | A1 |
20060289528 | Chiu | Dec 2006 | A1 |
20070016180 | Lee | Jan 2007 | A1 |
20070021741 | Abboud | Jan 2007 | A1 |
20070066972 | Ormsby | Mar 2007 | A1 |
20070185554 | Appling et al. | Aug 2007 | A1 |
20070203551 | Cronin | Aug 2007 | A1 |
20070208389 | Amundson | Sep 2007 | A1 |
20070230757 | Trachtenberg et al. | Oct 2007 | A1 |
20070270924 | McCann et al. | Nov 2007 | A1 |
20070276362 | Rioux | Nov 2007 | A1 |
20070282319 | van der Weide | Dec 2007 | A1 |
20070288079 | van der Weide | Dec 2007 | A1 |
20080033424 | Van Der Weide | Feb 2008 | A1 |
20080114345 | Arless et al. | May 2008 | A1 |
20080147056 | Van der Weide | Jun 2008 | A1 |
20080161890 | Lafontaine | Jul 2008 | A1 |
20080188868 | Weitzner | Aug 2008 | A1 |
20080188869 | Weitzner | Aug 2008 | A1 |
20080188871 | Smith | Aug 2008 | A1 |
20080188890 | Weitzner | Aug 2008 | A1 |
20080195226 | Williams | Aug 2008 | A1 |
20080221391 | Weitzner | Sep 2008 | A1 |
20080243176 | Weitzner | Oct 2008 | A1 |
20090005766 | Brannan | Jan 2009 | A1 |
20090054962 | Lefler | Feb 2009 | A1 |
20090076492 | Behnke | Mar 2009 | A1 |
20090118725 | Auth et al. | May 2009 | A1 |
20090187180 | Brannan | Jul 2009 | A1 |
20090187186 | Jakus | Jul 2009 | A1 |
20090196480 | Nields et al. | Aug 2009 | A1 |
20090222002 | Bonn | Sep 2009 | A1 |
20090306644 | Perry | Oct 2009 | A1 |
20090281536 | Beckman et al. | Nov 2009 | A1 |
20100023866 | Peck | Jan 2010 | A1 |
20100045558 | Rossetto | Feb 2010 | A1 |
20100045559 | Rossetto | Feb 2010 | A1 |
20100076424 | Carr | Mar 2010 | A1 |
20100081928 | Hyde et al. | Apr 2010 | A1 |
20100137796 | Perry et al. | Jun 2010 | A1 |
20100228244 | Hancock | Sep 2010 | A1 |
20100268223 | Coe | Oct 2010 | A1 |
20100286791 | Goldsmith | Nov 2010 | A1 |
20100292766 | Duong | Nov 2010 | A1 |
20100305561 | Prakash et al. | Dec 2010 | A1 |
20100312095 | Jenkins | Dec 2010 | A1 |
20100312096 | Guttman | Dec 2010 | A1 |
20100317962 | Jenkins | Dec 2010 | A1 |
20110077635 | Bonn et al. | Mar 2011 | A1 |
20110098696 | Brannan | Apr 2011 | A1 |
20110118723 | Turner | May 2011 | A1 |
20110118725 | Mayse | May 2011 | A1 |
20110213352 | Lee | Sep 2011 | A1 |
20110238060 | Lee, Jr. | Sep 2011 | A1 |
20110238061 | van der Weide | Sep 2011 | A1 |
20110257647 | Mayse | Oct 2011 | A1 |
20110301587 | Deem | Dec 2011 | A1 |
20120016358 | Mayse | Jan 2012 | A1 |
20120053577 | Lee | Mar 2012 | A1 |
20120116286 | Williams | May 2012 | A1 |
20120182134 | Doyle | Jul 2012 | A1 |
20120194409 | Brannan | Aug 2012 | A1 |
20120203216 | Mayse | Aug 2012 | A1 |
20120203222 | Mayse | Aug 2012 | A1 |
20120209257 | van der Weide | Aug 2012 | A1 |
20120209261 | Mayse | Aug 2012 | A1 |
20120209296 | Mayse | Aug 2012 | A1 |
20120232544 | Willyard | Sep 2012 | A1 |
20120232549 | Willyard | Sep 2012 | A1 |
20120310228 | Bonn | Dec 2012 | A1 |
20120316551 | van der Weide | Dec 2012 | A1 |
20120316552 | Mayse | Dec 2012 | A1 |
20120316559 | Mayse | Dec 2012 | A1 |
20130004037 | Scheuering | Jan 2013 | A1 |
20130023866 | Stringham | Jan 2013 | A1 |
20130072924 | Burgener | Mar 2013 | A1 |
20130116679 | van der Weide et al. | May 2013 | A1 |
20130123598 | Jenkins | May 2013 | A1 |
20130131496 | Jenkins | May 2013 | A1 |
20130165915 | Thiel | Jun 2013 | A1 |
20130259335 | Mallya et al. | Oct 2013 | A1 |
20130306543 | Beisser | Nov 2013 | A1 |
20130338530 | Kassab | Dec 2013 | A1 |
20140005706 | Gelfand | Jan 2014 | A1 |
20140046174 | Ladtkow | Feb 2014 | A1 |
20140046176 | Ladtkow | Feb 2014 | A1 |
20140152656 | Yoo | Jun 2014 | A1 |
20140163664 | Goldsmith | Jun 2014 | A1 |
20140276033 | Brannan | Sep 2014 | A1 |
20140276200 | Brannan | Sep 2014 | A1 |
20150148792 | Kim | May 2015 | A1 |
20150150628 | Buysse | Jun 2015 | A1 |
20150164587 | Bonn et al. | Jun 2015 | A1 |
20150190193 | Mayse | Jul 2015 | A1 |
20150250540 | Behdad | Sep 2015 | A1 |
20150351839 | Brannan | Dec 2015 | A1 |
20150374438 | van der Weide | Dec 2015 | A1 |
Number | Date | Country |
---|---|---|
2015202149 | May 2015 | AU |
2579361 | Oct 2003 | CN |
1593353 | Mar 2005 | CN |
1703168 | Nov 2005 | CN |
2753408 | Jan 2006 | CN |
201267529 | Jul 2009 | CN |
101511295 | Aug 2009 | CN |
101563042 | Oct 2009 | CN |
1186274 | Mar 2002 | EP |
1265532 | Dec 2002 | EP |
1395190 | Mar 2004 | EP |
1450710 | Sep 2004 | EP |
1499251 | Jan 2005 | EP |
1542607 | Jun 2005 | EP |
1723922 | Nov 2006 | EP |
2098184 | Sep 2009 | EP |
2295000 | Mar 2011 | EP |
2316370 | May 2011 | EP |
1659969 | Oct 2012 | EP |
2388039 | Nov 2003 | GB |
2406521 | Apr 2005 | GB |
10-192286 | Jul 1998 | JP |
2002-541884 | Dec 2002 | JP |
2003-530139 | Oct 2003 | JP |
2003-534037 | Nov 2003 | JP |
2004-188179 | Jul 2004 | JP |
2005-522274 | Jul 2005 | JP |
2007-029457 | Feb 2007 | JP |
2007-532024 | Nov 2007 | JP |
2008-142467 | Jun 2008 | JP |
2009-006150 | Jan 2009 | JP |
2009-521264 | Jun 2009 | JP |
2009-521967 | Jun 2009 | JP |
2009-207898 | Sep 2009 | JP |
2009-285463 | Dec 2009 | JP |
2010-505573 | Feb 2010 | JP |
2010-050975 | Mar 2010 | JP |
2011-511538 | Apr 2011 | JP |
2011-092720 | May 2011 | JP |
2011-152414 | Aug 2011 | JP |
9204934 | Apr 1992 | WO |
199309845 | May 1993 | WO |
95004385 | Sep 1995 | WO |
1997048449 | Dec 1997 | WO |
9956643 | Nov 1999 | WO |
0057811 | Oct 2000 | WO |
0170114 | Sep 2001 | WO |
03039385 | May 2003 | WO |
03086498 | Oct 2003 | WO |
03088806 | Oct 2003 | WO |
03088858 | Oct 2003 | WO |
2003086190 | Oct 2003 | WO |
04004586 | Jan 2004 | WO |
04026122 | Jan 2004 | WO |
04033039 | Apr 2004 | WO |
2004084748 | Oct 2004 | WO |
WO 2004084748 | Oct 2004 | WO |
04112628 | Dec 2004 | WO |
2005011049 | Feb 2005 | WO |
05034783 | Apr 2005 | WO |
05110265 | Nov 2005 | WO |
06002943 | Jan 2006 | WO |
0605579 | Jan 2006 | WO |
06008481 | Jan 2006 | WO |
2006002843 | Jan 2006 | WO |
2006004585 | Jan 2006 | WO |
2006084676 | Aug 2006 | WO |
2006127847 | Nov 2006 | WO |
2006122149 | Nov 2006 | WO |
2007076924 | Jul 2007 | WO |
2007112103 | Oct 2007 | WO |
2008008545 | Jan 2008 | WO |
2008044013 | Apr 2008 | WO |
08142686 | Nov 2008 | WO |
2010067360 | Jun 2010 | WO |
11008903 | Jan 2011 | WO |
2011017168 | Feb 2011 | WO |
2011140087 | Nov 2011 | WO |
2013173481 | Nov 2013 | WO |
Entry |
---|
International Search Report, PCT/US2006/017981, dated Sep. 7, 2006. |
International Search Report, PCT/US2006/033341, dated Aug. 17, 2007. |
International Search Report, PCT/US06/032811, dated Jan. 25, 2007. |
International Search Report, PCT/US06/031644, dated Aug. 17, 2007. |
Golio, “The RF and microwave handbook” Edition: 2. Published by CRC Press, 2001 ISBN 0849338592X, 97808493859626. |
Brace, Christopher et al., “Analysis and experimental validation of a triaxial antenna for microwave tumor ablation,” IEEE MTTS Int Microw Symp. Jun. 3, 2004(6-11), 1437-1440. |
Brace, Christopher et al., “Microwave Ablation with a Triaxial Antenna: Results in ex vivo Bovine Liver,” IEEE Transations on Microwave Theory and Techniques, vol. 53, No. 1 Jan. 2005. |
Seki, Toshihito, et al., “Ultrasonically Guided Percutaneous Microwave Coagulation Therapy for Small Hepatocellular Carcinoma,” Cancer, Aug. 1, 1994, vol. 74, No. 3, pp. 817-825. |
Head, Hayden W., et al., “Thermal Ablation for Hepatocellular Carcinoma,” Gastroenterology, 2004:127:S167-S178. |
English translation of a Decision of Refusal from related Japanese Patent Application No. 2013-509179, dated Jun. 30, 2015. |
International Search Report & Written Opinion, International Patent Application No. PCT/US2017/027424, dated Oct. 9, 2017. |
“Carbon dioxide.” Carbon dioxide—New World Encyclopedia. Web. <http://www.newworldencyclopedia.org/entry/Carbon_dioxide>. |
International Search Report re: PCT/US16/58888 dated Feb. 15, 2017. |
International Search Report re: PCT/US2016/058890 dated Jan. 19, 2017. |
Supplementary European Search Report re: EP11778168 dated Sep. 24, 2013. |
U.S. Appl. No. 09/847,181, filed May 1, 2001. |
U.S. Appl. No. 10/370,179, filed Feb. 19, 2003. |
U.S. Appl. No. 10/834,802, filed Apr. 29, 2004. |
U.S. Appl. No. 10/961,761, filed Oct. 7, 2004. |
U.S. Appl. No. 10/961,994, filed Oct. 7, 2004. |
U.S. Appl. No. 10/980,699, filed Nov. 3, 2004. |
U.S. Appl. No. 11/053,987, filed Feb. 8, 2005. |
U.S. Appl. No. 11/236,985, filed Sep. 28, 2005. |
U.S. Appl. No. 11/237,136, filed Sep. 28, 2005. |
U.S. Appl. No. 11/237,430, filed Sep. 28, 2005. |
U.S. Appl. No. 11/440,331, filed May 24, 2006. |
U.S. Appl. No. 11/452,637, filed Jun. 14, 2006. |
U.S. Appl. No. 11/502,783, filed Aug. 11, 2006. |
U.S. Appl. No. 11/514,628, filed Sep. 1, 2006. |
U.S. Appl. No. 11/728,428, filed Mar. 26, 2007. |
U.S. Appl. No. 11/728,457, filed Mar. 26, 2007. |
U.S. Appl. No. 11/728,460, filed Mar. 26, 2007. |
U.S. Appl. No. 60/679,722, filed May 10, 2005. |
U.S. Appl. No. 60/785,466, filed Mar. 24, 2006. |
U.S. Appl. No. 60/785,467, filed Mar. 24, 2006. |
U.S. Appl. No. 60/785,690, filed Mar. 24, 2006. |
U.S. Appl. No. 60/831,055, filed Jul. 14, 2006. |
European Search Report, EP Patent Application No. 17168163.8, dated Sep. 13, 2017. |
Guy, AW (1971) IEEE Trans. Microwave Theory Tech. 19 pp. 205-214. |
European Search Report dated March 9, 2015, EP Patent Application No. 14189493.1. |
International Search Report re: PCT/US2007/007408 dated Aug. 31, 2007. |
Notice Regarding Extended European Search Report, EP Patent Application No. 11778168 dated Oct. 2, 2013. |
International Preliminary Report on Patentability re: PCT/US2007/007408 dated Sep. 30, 2008. |
International Preliminary Report on Patentability re: PCT/US2016/058888 dated Dec. 11, 2017. |
International Preliminary Report on Patentability re: PCT/US2016/058890 dated May 11, 2018. |
European Search Report, EP Patent Application No. 06802385.2, dated Mar. 3, 2009. |
European Search Report, EP Patent Application No. 11778168, dated Oct. 2, 2013. |
International Preliminary Report, PCT/US2007/007464, dated Sep. 30, 2008. |
International Search Report, PCT/US2005/014534, dated Nov. 29, 2005. |
International Search Report, PCT/US2006/028821, dated Mar. 21, 2007. |
Guy, AW (1971) IEEE Trans. Microwave Theory Tech. 19 pp. 189-217. |
European Search Report, EP Patent Application No. 12860249.7, dated Sep. 15, 2015. |
European Search Report, EP Patent Application No. 10806929.5, dated Feb. 21, 2013. |
European Search Report, EP Patent Application No. 07810483, dated Mar. 22, 2013. |
International Search Report, PCT/US2007/016082, dated Jul. 21, 2008. |
International Search Report, PCT/US2011/035000, dated Jan. 6, 2012. |
International Search Report, PCT/US2012/071310, dated Feb. 25, 2013. |
International Preliminary Report on Patentability, PCT/US2007/016082, dated Jan. 14, 2009. |
International Preliminary Report on Patentability, PCT/US2010/043558, dated Jan. 31, 2012. |
International Preliminary Report on Patentability, PCT/US2011/035000, dated Nov. 6, 2012. |
International Preliminary Report on Patentability, PCT/US2012/071310, dated Aug. 19, 2014. |
Number | Date | Country | |
---|---|---|---|
20080045938 A1 | Feb 2008 | US |
Number | Date | Country | |
---|---|---|---|
60831055 | Jul 2006 | US |